The relationship between HbA 1c and fasting plasma glucose in patients with increased plasma liver enzyme measurements

Diabetic Medicine

Volumn 29, Issue 6, 2012, Pages 742-747

  Christiansen, R ^a   Melholt Rasmussen, L ^a   Nybo, H ^b   Steenstrup, T ^c   Nybo, M ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b University of Southern Denmark ^*

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Diagnostic tool; Fasting plasma glucose; HbA 1c; Liver function tests; Pre analytical bias

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FASTING BLOOD GLUCOSE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRANSAMINASEMIA; MAJOR CLINICAL STUDY; MALE; ANALYSIS OF VARIANCE; BLOOD; DIABETES MELLITUS; DIET RESTRICTION; ENZYMOLOGY; LIVER; LIVER DISEASE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SEX RATIO;

ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; SEX DISTRIBUTION;

EID: 84861123658     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03543.x     Document Type: Article

References (25)

1. International Expert Committee. International expert committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
2. WHO. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation. WHO/NMH/CHP/CPM/11.1. Geneva: World Health Organization, 2011.
3. 1c a step forward for diagnosing diabetes? Br Med J 2009; 339: 4432.
4. Nathan DM; on behalf of the International Expert Committee. International expert committee report on the role of the A1c assay in the diagnosis of diabetes: response to Kilpatrick, Bloomgarden, and Zimmet. Diabetes Care 2009; 32: e160.
5. Trenti T, Cristiani A, Cioni G, Pentore R, Mussini C, Ventura E. Fructosamine and glycated haemoglobin as indices of glycemic control in patients with liver cirrhosis. Ric Clin Lab 1990; 20: 261-267.
6. Cacciatore L, Cozzolino G, Giardina MG, De Marco F, Sacca L, Esposito P et al. Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated haemoglobin levels in chronic liver disease. Diabetes Res 1988; 7: 185-188.
7. Nomura Y, Nanjo K, Miyano M, Kikuoka H, Kuriyama S, Maeda M et al. Hemoglobin A1 in cirrhosis of the liver. Diabetes Res 1989; 11: 177-180.
8. Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR et al. Determination of glycated haemoglobin in patients with advanced liver disease. World J Gastroenterol 2004; 10: 2284-2286.
9. Bando Y, Kanehara H, Toya D, Tanaka N, Kasayama S, Koga M. Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem 2009; 46: 368-372.
10. Stevens VJ, Fantl WJ, Newman CB, Sims RV, Cerami A, Peterson CM. Acetaldehyde adducts with hemoglobin. J Clin Invest 1981; 67: 361-369.
11. 1c chromatography in the FPLC method with MonoS cation exchanger. Clin Chim Acta 1998; 275: 53-61.
12. Jeppsson J-O, Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of hemoglobinA by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. Clin Chem 1986; 32: 1867-1872.
13. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31: 1473-1478.
14. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Mårtensson A et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004; 64: 271-284.
15. Westgard J. Desirable specifications for total error, imprecision, and bias, derived from intra- and inter-individual biologic variation. Available at Last accessed 19 August 2011.
16. Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 2004; 30: 398-408.
17. Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S et al. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev 2006; 22: 274-283.
18. Shetty A, Wilson S, Kuo P, Laurin JL, Howell CD, Johnson L et al. Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance. Transplantation 2000; 69: 2451-2454.
19. Nielsen MF, Caumo A, Aagaard NK, Chandramouli V, Schumann WC, Landau BR et al. Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological and insulin concentrations. Am J Physiol Gastrointest Liver Physiol 2005; 288: G1135-G1143.
20. Huisman THJ, Henson JB, Wilson JB. A new high-performance liquid chromatographic procedure to quantitate hemoglobinA and other minor hemoglobins in blood of normal, diabetic, and alcoholic individuals. J Lab Clin Med 1983; 102: 163-173.
21. Turpeinen U, Stenman U-H, Roine R. Liquid-chromatographic determination of acetylated hemoglobin. Clin Chem 1989; 35: 33-36.
22. Homaidan FR, Kricka LJ, Clark PMS, Jones SR, Whitehead TP. Acetaldehyde hemoglobin adducts: an unreliable marker of alcohol abuse. Clin Chem 1984; 30: 480-482.
23. Subhiyah BW, Al-Hindawi AY. Red cell survival and splenic accumulation of radiochromium in liver cirrhosis with splenomegaly. Br J Haematol 1967; 13: 773-778.
24. Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y et al. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 2001; 138: 332-337.
25. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.